Skip to main content
Home / Current Pharmaceutical Design, Volume 18, Number 36
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 18, Number 36, 2012

Articles

Free Content Editorial (Hot Topic :Treatment with Antidepressants)
pp. 5789-5790(2)
Author: Himmerich, Hubertus

Favourites:
ADD

Neurobiology of Depression and Novel Antidepressant Drug Targets
pp. 5791-5801(11)
Authors: Kern, Nikola; Sheldrick, Abigail J.; Schmidt, Frank M.; Minkwitz, Juliane

Favourites:
ADD

Sleep and Antidepressant Treatment
pp. 5802-5817(16)
Authors: Wichniak, Adam; Wierzbicka, Aleksandra; Jernajczyk, Wojciech

Favourites:
ADD

Therapeutic Drug Monitoring for Antidepressant Drug Treatment
pp. 5818-5827(10)
Authors: Ostad Haji, Elnaz; Hiemke, Christoph; Pfuhlmann, Bruno

Favourites:
ADD

Lack of Data on Depression-like States and Antidepressant Pharmacotherapy in Patients with Epilepsy: Randomised Controlled Trials are Badly Needed
pp. 5828-5836(9)
Authors: Kanemoto, Kousuke; Tadokoro, Yukari; J. Sheldrick, Abigail; Oshima, Tomohiro

Favourites:
ADD

Stress, Depression and Antidepressant Treatment Options in Patients Suffering from Multiple Sclerosis
pp. 5837-5845(9)
Authors: Schumann, Robert; Adamaszek, Michael; Sommer, Norbert; C. Kirkby, Kenneth

Favourites:
ADD

The Role of Transcranial Magnetic Stimulation in Treatment-Resistant Depression: A Review
pp. 5846-5852(7)
Authors: C. Lee, Jonathan; M. Blumberger, Daniel; B. Fitzgerald, Paul; J. Daskalakis, Zafiris; J. Levinson, Andrea

Favourites:
ADD

Genetics and Personalized Medicine in Antidepressant Treatment
pp. 5853-5878(26)
Authors: Gvozdic, Katarina; J. Brandl, Eva; L. Taylor, Danielle; J. Muller, Daniel

Favourites:
ADD

Epigenetics, Depression and Antidepressant Treatment
pp. 5879-5889(11)
Authors: Menke, Andreas; Klengel, Torsten; B. Binder, Elisabeth

Favourites:
ADD

The Role of Oxidative Stress in Depressive Disorders
pp. 5890-5899(10)
Authors: Maria Michel, Tanja; Pulschen, Dietrich; Thome, Johannes

Favourites:
ADD

Glucose Metabolism and Antidepressant Medication
pp. 5900-5919(20)
Authors: M. Hennings, Johannes; Schaaf, Ludwig; Fulda, Stephany

Favourites:
ADD

Inflammatory Cytokines, Growth Factors, and Depression
pp. 5920-5935(16)
Author: Lotrich, Francis

Favourites:
ADD

Health Service Utilization and Costs of Depressive Symptoms in Late Life - A Systematic Review
pp. 5936-5957(22)
Authors: Luppa, Melanie; Sikorski, Claudia; Motzek, Tom; Konnopka, Alexander; Konig, Hans-Helmut; G. Riedel-Heller, Steffi

Favourites:
ADD

Choice of Treatment with Antidepressants: Influencing Factors
pp. 5958-5975(18)
Authors: Himmerich, Hubertus; W. Wranik, Dominika

Favourites:
ADD

The Canadian Biomarker Integration Network in Depression (CAN-BIND): Advances in Response Prediction
pp. 5976-5989(14)
Authors: H. Kennedy, Sidney; Downar, Jonathan; R. Evans, Kenneth; Feilotter, Harriet; W. Lam, Raymond; M. MacQueen, Glenda; Milev, Roumen; V. Parikh, Sagar; Rotzinger, Susan; Soares, Claudio

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content